Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Caladrius Biosciences Inc. (CLBS)

2.96   -0.05 (-1.66%) 05-24 15:59
Open: 2.95 Pre. Close: 3.01
High: 3.02 Low: 2.95
Volume: 2,943 Market Cap: 31M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.024 - 3.04 3.04 - 3.052
Low: 2.915 - 2.931 2.931 - 2.944
Close: 2.937 - 2.962 2.962 - 2.982

Technical analysis

as of: 2019-05-26 10:09:49 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 3.55     One year: 3.74
Support: Support1: 2.77    Support2: 2.30
Resistance: Resistance1: 3.04    Resistance2: 3.20
Pivot: 2.98
Moving Average: MA(5): 3.00     MA(20): 2.98
MA(100): 3.88     MA(250): 4.58
MACD: MACD(12,26): -0.06     Signal(9): -0.09
Stochastic oscillator: %K(14,3): 50.41     %D(3): 54.47
RSI: RSI(14): 44.48
52-week: High: 11.65  Low: 2.77  Change(%): -26.9
Average Vol(K): 3-Month: 2908  10-Days: 2137

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CLBS has closed above bottom band by 40.9%. Bollinger Bands are 71.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to CLBS's normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 14 Feb 2019 18:06:33 Z
Mid-Morning Market Update: Markets Open Lower; Cisco Earnings Top Estimates

Wed, 23 Jan 2019 16:49:54 Z
What Makes Caladrius Biosciences (CLBS) a New Buy Stock

Fri, 02 Nov 2018 19:09:40 Z
Agios (AGIO) Q3 Earnings Beat, Tibsovo Sales Drive Stock

Thu, 01 Nov 2018 19:07:54 Z
Acorda (ACOR) Q3 Earnings Top Estimates, Ampyra Sales View Up

Mon, 15 Oct 2018 18:06:52 Z
AcelRx's Dsuvia Gets FDA Committee Approval, Shares Rally

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Shares Out. (M) 10.38
Shares Float (M) 2.31
% Held by Insiders
% Held by Institutions 9.80
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS Est. Current Year -2.420
EPS Est. Next Year -2.950
EPS Est. Next Quarter -0.770
Forward EPS 1.#IO
Book Value (p.s.) 0.900
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -31.7
Return on Equity (ttm) -38.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E Growth Ratio
P/BV 3.29

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.